Curidium Medica plc ("Curidium" or the "Company") Curidium Announces Director's Purchase of Company Shares LONDON, UK, 20 May 2008, Curidium Medica plc, (LSE :CUR ), a personalized medicine company focused on bringing the right drug to the right patient, announced today that director Rob Smith, Finance Director, today has purchased 1,825 ordinary shares in the Company at a price of 54.8 pence per share. Following this transaction, Rob Smith is interested in 8,491 shares representing approximately 0.046 per cent of the Company's total issued share capital. - END - For further information, please contact: Rob Smith +44 (0)20 7383 5345 Finance Director, Curidium Medica plc Charlie Cunningham +44 (0)20 7600 1658 JM Finn Capital Markets Ltd Billy Clegg / Edward Westropp / Annie Evangeli + 44 (0)20 7831 3113 Financial Dynamics This information is provided by RNS The company news service from the London Stock Exchange END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com